Jackson R. Pierce
Biochemistry, Genetics and Molecular Biology · Purdue University West Lafayette
Publications
56
Citations
83
Est. group size
~3
Recurring co-author estimate
Active years
45
Publishing since 1981
Jackson R. Pierce studies how cells sense double-stranded RNA (a molecular signal that can trigger immune-like alarm responses) and how cancer cells, particularly breast cancer cells, suppress or exploit this sensing system. Recent work focuses on proteins like PKR, PACT, DHX9, and ADAR1, which regulate RNA-triggered immune responses, and explores how disrupting these proteins might be used as a cancer therapy strategy. This research sits at the intersection of RNA biology, cancer biology, and innate immune signaling.
Publication records show no listed output from 2017-2023 followed by a sharp concentration of activity in 2024, suggesting either a recent surge in output or a gap in earlier indexed records rather than a steady long-term trend.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- PACT suppresses PKR activation through dsRNA binding and dimerization, and is a therapeutic target for triple-negative breast cancer
RNA · 2025
- PACT suppresses PKR activation through dsRNA binding and dimerization, and is a therapeutic target for triple-negative breast cancer
bioRxiv (Cold Spring Harbor Laboratory) · 2025
- FIGURE 5 from Induction of Viral Mimicry Upon Loss of DHX9 and ADAR1 in Breast Cancer Cells
2024
- Induction of Viral Mimicry Upon Loss of DHX9 and ADAR1 in Breast Cancer Cells
Cancer Research Communications · 2024
- Suppression of double-stranded RNA sensing in cancer: molecular mechanisms and therapeutic potential
Biochemical Society Transactions · 2024
- Activation of PKR by a short-hairpin RNA
Scientific Reports · 2024
- Activation of PKR by a short-hairpin RNA
bioRxiv (Cold Spring Harbor Laboratory) · 2024
- Supplementary Figure 7 from Induction of Viral Mimicry Upon Loss of DHX9 and ADAR1 in Breast Cancer Cells
2024
- Supplementary Figure 11 from Induction of Viral Mimicry Upon Loss of DHX9 and ADAR1 in Breast Cancer Cells
2024
- Supplementary Figure 11 from Induction of Viral Mimicry Upon Loss of DHX9 and ADAR1 in Breast Cancer Cells
2024
- Source Data Figures from Induction of Viral Mimicry Upon Loss of DHX9 and ADAR1 in Breast Cancer Cells
2024
- FIGURE 1 from Induction of Viral Mimicry Upon Loss of DHX9 and ADAR1 in Breast Cancer Cells
2024
- Supplementary Figure 6 from Induction of Viral Mimicry Upon Loss of DHX9 and ADAR1 in Breast Cancer Cells
2024
- FIGURE 1 from Induction of Viral Mimicry Upon Loss of DHX9 and ADAR1 in Breast Cancer Cells
2024
- Supplementary Figure 13 from Induction of Viral Mimicry Upon Loss of DHX9 and ADAR1 in Breast Cancer Cells
2024
- bioRxiv (Cold Spring Harbor Laboratory)×2
- Cancer Research Communications×1
- Biochemical Society Transactions×1
- RNA×1
- Scientific Reports×1
- Kyle A. Cottrell
Biochemistry, Genetics and Molecular Biology · Purdue University West Lafayette
- Zan Xu
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Jered Myslinski
Biochemistry, Genetics and Molecular Biology · Indiana University
- Heather A. Hundley
Biochemistry, Genetics and Molecular Biology · Indiana University
- Emily A. Erdmann
Biochemistry, Genetics and Molecular Biology · Indiana University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 20, 2026.
Claim or correct this profile